Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Ueda

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 8, 2023
Transient Non-Collinear Magnetic State for All-Optical Magnetization SwitchingSergii Parchenko, Antoni Frej, Hiroki Ueda, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation FactorsKeiichi Nakata, Shuji Ueda, Hitomi Matsunaga, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 15, 2024
Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysisHiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, et al.
Computational and Structural Biotechnology Journal|February 15, 2024
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviationFeifei Wei, Taku Kouro, Yuko Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2022
Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitorsYuhei Harutani, Yuichi Ozawa, Eriko Murakami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 2022
[Perioperative management of laparoscopic cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab treatment]Moyu Kimura, Yu Nishiyama, Hiroki Ueda, et al.
Cancer Science|December 28, 2025
Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral FibrosisAtsushi Nara, Shu Shimada, Yoshimitsu Akiyama, et al.
Nature Biotechnology|June 7, 2020
Publisher Correction: Base editors for simultaneous introduction of C-to-T and A-to-G mutationsRina C Sakata, Soh Ishiguro, Hideto Mori, et al.
Nature Biotechnology|June 3, 2020
Base editors for simultaneous introduction of C-to-T and A-to-G mutationsRina C Sakata, Soh Ishiguro, Hideto Mori, et al.
Stem Cell Reports|January 24, 2017
Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived CardiomyocytesTadahiro Shinozawa, Koki Nakamura, Masanobu Shoji, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 8, 2023
Transient Non-Collinear Magnetic State for All-Optical Magnetization SwitchingSergii Parchenko, Antoni Frej, Hiroki Ueda, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation FactorsKeiichi Nakata, Shuji Ueda, Hitomi Matsunaga, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 15, 2024
Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysisHiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, et al.
Computational and Structural Biotechnology Journal|February 15, 2024
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviationFeifei Wei, Taku Kouro, Yuko Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2022
Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitorsYuhei Harutani, Yuichi Ozawa, Eriko Murakami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 2022
[Perioperative management of laparoscopic cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab treatment]Moyu Kimura, Yu Nishiyama, Hiroki Ueda, et al.
Cancer Science|December 28, 2025
Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral FibrosisAtsushi Nara, Shu Shimada, Yoshimitsu Akiyama, et al.
Nature Biotechnology|June 7, 2020
Publisher Correction: Base editors for simultaneous introduction of C-to-T and A-to-G mutationsRina C Sakata, Soh Ishiguro, Hideto Mori, et al.
Nature Biotechnology|June 3, 2020
Base editors for simultaneous introduction of C-to-T and A-to-G mutationsRina C Sakata, Soh Ishiguro, Hideto Mori, et al.
Stem Cell Reports|January 24, 2017
Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived CardiomyocytesTadahiro Shinozawa, Koki Nakamura, Masanobu Shoji, et al.
Pageof 15